Browsing by Author Papatheodoridis, G

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 19 of 19
TitleAuthor(s)Issue DateViews
 
2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B
Journal:Gastroenterology
Liaw, YGane, ELeung, NZeuzem, SWang, YLai, CLHeathcote, EJManns, MBzowej, NNiu, JHan, SHwang, SGCakaloglu, YTong, MJPapatheodoridis, GChen, YBrown, NAAlbanis, EGalil, KNaoumov, NV
2009
201
 
Characterization of HBsAg decline in the Tenofovir disoproxil fumarate (TDF) and peginterferon alfa 2A (PEG) combination study for chronic hepatitis B (CHB)
Proceeding/Conference:Hepatology International
Chan, HLYKadayifci, APapatheodoridis, GYuen, MFChien, RNKwan, WCPLin, LDinh, PMartins, EBCharuworn, PSubramanian, GMMchutchison, JGPetersen, JShiffman, MReesink, HWLim, SGLim, YSMarcellin, P
2015
119
 
Differential patterns of virological relapse and remission after discontinuation of tenofovir disoproxil fumarate or entecavir: results from a global, multi-ethnic cohort of patients with chronic hepatitis B virus infection (RETRACT-B Study)
Proceeding/Conference:Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology
Choi, HSJHirode, GChen, CHSu, T-HWong, GLHSeto, WKWHees, SVPapatheodoridi, MBrakenhoff, SLens, SSarowar, AChien, R-NFeld, JJForns, XSonneveld, MJPapatheodoridis, GVanwolleghem, TYuen, RMFChan, HLYKao, J-HHsu, Y-CCornberg, MHansen, BEJeng, WJJanssen, HLY
2021
 
Earlier and more frequent virological and clinical relapse after cessation of tenofovir disoproxil fumarate versus entecavir therapy: Results from a large, global, multi-ethnic cohort of chronic hepatitis B patients (RETRACT-B study)
Proceeding/Conference:Journal of Hepatology
Choi, HSJHirode, GChen, CHSu, THWong, GLHSeto, WKWHees, SVPapatheodoridi, MBrakenhoff, SLens, SSarowar, AChien, RNFeld, JForns, XSonneveld, MPapatheodoridis, GVanwolleghem, TYuen, RMFChan, HKao, JHHsu, YCCornberg, MHansen, BJeng, RWJJanssen, H
2021
11
 
HBsAg loss after nucleo(s)tide analogue withdrawal: relationship with viral antigen levels and hbv genotype
Proceeding/Conference:Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology
Sonneveld, MJChiu, S-MPark, JYKaewdech, ASeto, WKWTanaka, YCarey, IPapatheodoridi, MVan Bömmel, FBrakenhoff, SBerg, TZoulim, FAhn, SHDalekos, GNErler, NSZu Siederdissen, CNWedemeyer, HCornberg, MYuen, RMFAgarwal, KBoonstra, AButi, MPiratvisuth, TPapatheodoridis, GChen, CHMaasoumy, BCREATE study group,
2021
 
HBsAg loss is higher among caucasians compared to Asians after stopping nucleos(t)ide analogue therapy: results from a large, global, multi-ethnic cohort of patients with chronic hepatitis B (RETRACT-B study)
Proceeding/Conference:Hepatology
Hirode, GChoi, HSJSu, THWong, GLHSeto, WKWHees, SVPapatheodoridi, MBrakenhoff, SLens, SSarowar, AChien, RNForns, XSonneveld, MJPapatheodoridis, GVanwolleghem, TYuen, RMFChan, HLYKao, JHHsu, YCChen, CHHansen, BECornberg, MJeng, WJJanssen, HLARETRACT-B Study Group,
2020
15
 
Hepatic decompensation and hepatocellular carcinoma after stopping nucleos (t)ide analogue therapy: Results from a large, global, multi-ethnic cohort of patients with chronic hepatitis B (RETRACT-B study)
Proceeding/Conference:Journal of Hepatology
Hirode, GHansen, BChen, CHSu, THWong, GLHSeto, WKWHees, SVPapatheodoridi, MBrakenhoff, SLens, XChoi, HSJChien, RNFeld, JForns, XSonneveld, MPapatheodoridis, GVanwolleghem, TYuen, RMFChan, HKao, JHHsu, YCCornberg, MJeng, RWJJassen, H
2021
7
 
Higher rates of virological relapse after nucleos (t)ide analogue withdrawal in HBeAg-negative versus positive chronic hepatitis B patients: results from a global, multi-ethnic cohort of patients with chronic hepatitis B (RETRACT-B Study). Poster Presentation (SAT415)
Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology
Choi, HSJHirode, GChen, C-HSu, T-HPapatheodoridi, MLens, SHees, SVBrakenhoff, SChien, R-NSeto, WKWWong, GFeld, JChan, HLYYuen, RMFSonneveld, MVanwolleghem, TForns, XPapatheodoridis, GKao, J-HHsu, Y-CCornberg, MHansen, BJeng, R W-JJanssen, H
2022
 
Low HBcrAg and HBsAg levels identify patients most likely to achieve sustained response after nucleos(t)ide analogue cessation: results from a global individual patient data meta-analysis (create study)
Proceeding/Conference:Journal of Hepatology
Sonneveld, MPark, JYSeto, WKWTanaka, YCarey, IPapatheodoridi, MZoulim, FAhn, SHDalekos, GHoener zu Siederdissen, CCornberg, MYuen, RMFAgarwal, KBoonstra, AButi, MPapatheodoridis, GMaasoumy, B
2020
31
 
Normal values of liver stiffness as measured by transient elastography: pooled individual participant data meta-analysis from 26 studies and 14,883 participants
Proceeding/Conference:Journal of Hepatology
Bazerbachi, FHaffar, SWang, ZGonzález, JCArias-Loste, MTCrespo, JDarwish-Murad, SIkram, MAPetta, SBerzuini, APrati, Dde Lédinghen, VWong, VDel Poggio, PChávez-Tapia, NCChen, YPCheng, PNYuen, RMFDas, KChowdhury, ACaballería, LFabrellas, NGinès, PKumar, MSarin, SKConti, FAndreone, PSirli, RCortez-Pinto, HCarvalhana, SSugihara, TKim, SUParikh, PChayama, KCorpechot, CKim, KMPapatheodoridis, GAlsebaey, AOlynyk, JKGan, EKamath, PWatt, KDMurad, MH
2017
65
 
Nucleos(t)ide analogue withdrawal in chronic hepatitis B patients leads to limited sustained remission in the absence of HBsAg loss: results from the RETRACT-B study. Oral Presentation.
Proceeding/Conference:The Liver Meeting 2021 (AASLD 2021), 12-15 November 2021. Hepatology
Hirode, GHansen, BEChen, C-HSu, T-HPapatheodoridi, MLens, SHees, SVBrakenhoff, SChoi, HSJChien, RNSeto, WKWWong, GLHFeld, JJChan, HLYYuen, RMFSonneveld, MJVanwolleghem, TForns, XPapatheodoridis, GKao, J-HHsu, Y-CCornberg, MCornberg, W-JJanssen, HLARETRACT-B Study Group,
2021
 
Prediction of sustained response after nucleo(s)tide analogue cessation using HBsAg and HBcrAg levels – a multicenter study (CREATE)
Proceeding/Conference:Hepatology
Sonneveld, MJPark, JYKaewdech, ASeto, WKWTanaka, YCarey, IPapatheodoridi, MVan Bömmel, FBerg, TZoulim, FAhn, SHDalekos, GNErier, NSHöner zu SiederdissenC, CWedemeyer, HComberg, MYuen, RMFAgarwal, KBoonstra, AFerret, MABPiratvisuth, TPapatheodoridis, GMaasoumy, BCREATE study group,
2020
12
 
Prediction Of Sustained Response After Nucleo(s)tide Analogue Cessation Using Hbsag And Hbcrag Levels – A Multicenter Study (create)
Journal:Clinical Gastroenterology and Hepatology
Sonneveld, MJPark, JYKaewdech, ASeto, WKTanaka, YCarey, IPapatheodoridi, Mvan Bommel, FBerg, TZoulim, FAhn, SHDalekos, GNErler, NSHoner zu Siederdissen, CWedemeyer, HCornberg, MYuen, MFAgarwal, KBoonstra, AButi, MPiratvisuth, TPapatheodoridis, GMaasoumy, B
2020
36
 
Presence of Biopsy-Proven Histologic Damage (Necroinflammation and Fibrosis) is Common Even When ALT is Less Than 2 x ULN in Patients with Chronic Hepatitis B (CHB) in Entecavir Studies ETV-022 (HBeAg+) and ETV-027 (HBeAg-)
Proceeding/Conference:Digestive Disease Week
Terrault, NKim, WRLim, SGPapatheodoridis, GAlberti, AYuen, RMFGoodman, ZDVaughan, JWilber, RKreter, B
2007
91
 
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels
Journal:Journal of Hepatology
Sonneveld, MJChiu, SMPark, JYBrakenhoff, SMKaewdech, ASeto, WKWTanaka, YCarey, IPapatheodoridi, Mvan Bommel, FBerg, TZoulim, FAhn, SHDalekos, GSErler, NSHoner zu Siederdissen, CWedemeyer, HCornberg, MYuen, RMFAgarwal, KBoonstra, AButi, MPiratvisuth, TPapatheodoridis, GChen, CHMaasoumy, B
2022
6
 
Prolonged efficacy and safety of 3 years of continuous telbivudine treatment in pooled data from globe and 015 studies in chronic hepatitis B patients
Proceeding/Conference:Journal of Hepatology
Hsu, CWChen, YCLiaw, YFGane, EManns, MZeuzem, SWang, YLai, CLHou, JLeung, NBzowej, NNiu, JJia, JHwang, SGCakaloglu, YRen, HPapatheodoridis, GChen, YBao, WLopez, P
2009
118
 
Range of Normal Liver stiffness and Predictors of Suspected Advanced Fibrosis in Apparently Healthy Individuals: A Pooled Analysis of 16,082 Participants
Journal:Clinical Gastroenterology and Hepatology
Bazerbachi, FHaffar, SWang, ZGonzález, JCArias-Loste, MTCrespo, JDarwish-Murad, SIkram, MAOlynyk, JKGan, EPetta, SBerzuini, APrati, Dde Lédinghen, WWong, VWDel Poggio, PChávez-Tapia, NCChen, YPCheng, PNYuen, RMFDas, KChowdhury, ACaballeria, LFabrellas, NGinès, PKumar, MSarin, SKConti, FAndreone, PSirli, RCortez-Pinto, HCarvalhana, SSugihara, TKim, SUParikh, PChayama, KCorpechot, CKim, KMPapatheodoridis, GAlsebaey, AKamath, PSMurad, MHWatt, K
2019
71
 
Telbivudine improves renal function in patients with chronic hepatitis B
Journal:Gastroenterology
Gane, EJDeray, GLiaw, YFLim, SGLai, CLRasenack, JWang, YPapatheodoridis, GDi Bisceglie, AButi, MSamuel, DUddin, ABosset, STrylesinski, A
2014
44
 
Viral and ALT kinetics after nucleos (t)ide analogue withdrawal among patients who remain off-therapy: results from a global, multi-ethnic cohort of chronic hepatitis B patients (RETRACT-B study). Poster Presentation (SAT400)
Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology
Hirode, GHansen, BChen, C-HSu, T-HPapatheodoridi, MLens, SHees, SVBrakenhoff, SChoi, SHJChien, R-NSeto, WKWWong, GFeld, JChan, HLYYuen, RMFSonneveld, MVanwolleghem, TForns, XPapatheodoridis, GKao, J-HHsu, Y-CCornberg, MJeng, R W-JJanssen, H
2022
Showing results 1 to 19 of 19